Gandotinib
N/A
Report date: 2022/07/04 19:38:02
NME
Base Information
Drug NameGandotinib
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[9]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A
Develop Information
Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active Indications
Inactive Indications +[4]
Other Information
ATC CodeN/A
Related LinksKEGG